Fig. 1.
Changes in mean arterial blood pressure (MAP). Angiotensin-converting enzyme-1 (ACEI) indicates the start of enalapril treatment. *P < 0.001 vs. other 2 groups by 2-way repeated measures ANOVA (n = 7).
Changes in mean arterial blood pressure (MAP). Angiotensin-converting enzyme-1 (ACEI) indicates the start of enalapril treatment. *P < 0.001 vs. other 2 groups by 2-way repeated measures ANOVA (n = 7).